MedWatch

Stallergenes Greer production back to full capacity after years of limited activity

An IT breakdown in 2015 has been the thorn in the side of Stallergenes Greer, which has only now regained full production capacity as it re-launches its series of allergy vaccines in Spain and Italy.

Photo: Stallergenes Greer/PR

French allergy firm Stallergenes Greer is finally back on track with production at its facilities in Southern Paris, it reports in a press release.

Back in 2015, Stallergenes was ordered to stop all production and distribution based at its factory in Antony by the French National Agency for the Safety of Medicines and Health Products (ANSM). Some products were recalled in France.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs